<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05034224</url>
  </required_header>
  <id_info>
    <org_study_id>2021-4</org_study_id>
    <nct_id>NCT05034224</nct_id>
  </id_info>
  <brief_title>Coronary Sinus Pressure and Microvascular Disease</brief_title>
  <acronym>MACCHUS</acronym>
  <official_title>MACCHUS: ModulAtion of Cardiac Coronary Sinus Hemodynamics to Develop a New Treatment for microvascUlar diseaSe. A Single Center, Randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johannes Gutenberg University Mainz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      MACCHUS is a randomized, single-center, controlled, cross-over interventional study in which&#xD;
      coronary artery resistances will be measured at baseline and during temporary occlusion of&#xD;
      the coronary sinus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to test whether an increase in coronary sinus pressure leads to a&#xD;
      change in coronary microvascular resistances in patients with angina pectoris and with an&#xD;
      indication to measurement of microvascular function as per clinical guidelines.&#xD;
&#xD;
      All patients with a clinical indication for the assessment of microvascular function will be&#xD;
      invited to participate and will sign the informed consent at least 24 hours before the study.&#xD;
      Patients with an index of microvascular resistances &gt;25 (i.e. evidence of microvascular&#xD;
      dysfunction) will undergo study-specific procedures in the same session (i.e. no additional&#xD;
      invasive procedure is required for the study).&#xD;
&#xD;
      Study-specific procedures include the repetition of the assessment of microvascular&#xD;
      resistances at rest and during coronary sinus occlusion. Coronary sinus occlusion will be&#xD;
      achieved by inflating a balloon sized to ~70% of the diameter of the coronary sinus. Since&#xD;
      the implantation of a coronary sinus reducer is a therapeutic option for this type of&#xD;
      patients, also this procedure (inflation of an undersized balloon in the coronary sinus)&#xD;
      provides clinically relevant information (sizing of the vessel, effect on microvascular&#xD;
      resistances and feasibility of the intervention).&#xD;
&#xD;
      The primary goal of the study is to study the effect of coronary sinus occlusion on&#xD;
      microvascular resistances at rest and during hyperemia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 23, 2021</start_date>
  <completion_date type="Anticipated">August 23, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 23, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The study is a single-center, cross-over randomized trial to investigate the effect of coronary sinus occlusion on microvascular resistances.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Investigators performing the analysis of the data (post-hoc) and patients are blinded to the sequence of the interventions.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>DIfference in the index of microvascular resistances (balloon occlusion versus deflated balloon)</measure>
    <time_frame>1 Minute after balloon occlusion</time_frame>
    <description>The Index of microvascular resistances, calculated as (Pressure distal - coronary venous pressure ) x mean transit time, will be compared between the two arms</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Microvascular Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The index of microvascular resistances will be measured while a balloon placed in the coronary sinus is kept deflated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coronary sinus occlusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The index of microvascular resistances will be measured while a balloon placed in the coronary sinus is inflated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Swan-Ganz catheter placed in the coronary sinus - deflated</intervention_name>
    <description>A normal Swan-Ganz catheter will be advanced in the coronary sinus. The Balloon will be kept deflated during sham intervention. The index of microvascular resistances will be measured using the Abbott Pressure Wire X as per instructions for use durng both interventions.</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Swan-Ganz catheter placed in the coronary sinus - inflated</intervention_name>
    <description>A normal Swan-Ganz catheter will be advanced in the coronary sinus. The Balloon will be inflated to obtain coronary sinus occlusion during the active intervention. The index of microvascular resistances will be measured using the Abbott Pressure Wire X as per instructions for use durng both interventions.</description>
    <arm_group_label>Coronary sinus occlusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic coronary syndrome (including patients with anginal equivalents).&#xD;
&#xD;
          -  Reversible ischemia on non-invasive testing, indication to cardiac catheterization;&#xD;
&#xD;
          -  Indication to the assessment of microvascular function (note: patients will be asked&#xD;
             for participation and consented prior to the first measurement of microvascular&#xD;
             function, which will be conducted as per clinical indication; only those with evidence&#xD;
             of pure or mixed microvascular disease (index of microvascular resistances (IMR)&gt;25&#xD;
             will proceed into the study);&#xD;
&#xD;
          -  Willingness to participate and ability to understand, read and sign the informed&#xD;
             consent;&#xD;
&#xD;
          -  Age&gt;18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous CABG with patent grafts to the left anterior descending coronary&#xD;
&#xD;
          -  Epicardial coronary disease (FFR &lt;0.80 with evidence of a focal stenosis) in the left&#xD;
             anterior descending territory&#xD;
&#xD;
          -  Severe valvular heart disease&#xD;
&#xD;
          -  Any cardiomyopathy; pulmonary or renal disease&#xD;
&#xD;
          -  Inability to provide informed consent&#xD;
&#xD;
          -  Any disease reducing life expectancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Center of Cardiology, Cardiology I, university hospital Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rheinland-Pfalz</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tommaso Gori, Prof Dr, PhD</last_name>
      <phone>+49 (0) 6131 17 2729</phone>
      <email>tommaso.gori@unimedizin-mainz.de</email>
    </contact>
    <investigator>
      <last_name>Tommaso Gori, Prof Dr, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 23, 2021</study_first_submitted>
  <study_first_submitted_qc>August 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johannes Gutenberg University Mainz</investigator_affiliation>
    <investigator_full_name>Tommaso Gori</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

